|
RNTX Rein Therapeutics Inc 1420565 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-6,375,000.00 |
| Balance Sheet |
|
Current Assets
|
$41,453,000.00 |
|
Assets
|
$65,973,000.00 |
|
Current Liabilities
|
$9,709,000.00 |
|
Liabilities
|
$10,769,000.00 |
|
Equity
|
$55,204,000.00 |
|
Shares Out
|
85767032.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-12,064,000.00 |
|
Investing Cash Flow
|
$-35,073,000.00 |
| Market Analysis |
Market Cap
|
$67,755,955.28 |
|
Price
|
$0.80 |
|
BVPS
|
0.64 |
|
PB
|
1.23 |
|
EPS
|
-0.10 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:52 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RNTX documents filed with the SEC.
RNTX Filings
Clear
